(1 - 23 from 32
)
Sanofi to file next-gen insulin next year - PharmaTimes
www.pharmatimes.com
Sanofi is preparing to file U300, an improved version of its insulin blockbuster Lantus, with regulators on both sides of the Atlantic during the first half of...
CE Mark approval for Sanofis half-unit insulin reusable pen
www.buildingbetterhealthcare.com
“Everyone deserves high-quality care while learning to manage their diabetes, for the best chances in life,” said Pierre Chancel, senior vice ...
Sanofi Announces Positive Phase 3 Results for Toujeo® (insulin...
www.prnewswire.co.uk
... II further add to the growing positive Phase 3 data for Toujeo," said Pierre Chancel, Senior Vice President, Global Diabetes Division, Sanofi.
Sanofi and MannKind Announce Global Licensing Agreement for...
www.globenewswire.com
... discreet inhaler," said Pierre Chancel, Sanofi Senior Vice President Diabetes Division. "Afrezza is a further addition to our growing portfolio of ...
sorted by relevance / date